Description: This session at the SOA 1990 San Francisco Spring Meeting focuses on the connection between the pricing function and financial reporting, communicating financial information to senior management and asset/liability management.

Description: This paper presents multiple book reviews: Reports from Staff of U.S. House of Representatives Committee on Ways and Means and U.S. Senate Committee on Finance, Reports in Connection with Social Security Legislation 1975-77, 'Statement on Cost Comparisons of Individual Life Insurance Policies', by Canadian Institute of Actuaries, 'Investment Activities of Life Insurance Companies' from Huebner Foundation Lectures, 'The Life Insurance Industry's Marketing Dilemma' by Johns, 'The Future of Social Security' by Munnell, 'Social Security - Today and Tomorrow' by Ball, 'Mortality Table Construction' by Batten, 'Mortality Table Construction' by Batten, 'The Crisis in Social Security - Problems and Prospects' by Boskin, 'A History of Interest Rates' by Homer, 'Indexation of Pensions and Other Benefits' by Robert Myers, 'Life Insurance Accounting' by Strain, '1978 Annual Report of the Board of Trustees of the Federal Hospital Insurance Trust Fund...' by US Congress. Brief summaries of additional readings are also included.

Description: Presented at May 1986 Spring Meeting. This session discussion is about redetermination of 'Non-Guaranteed Pricing Elements Recommendations', actuarial responsibilities to the various publics relative to nonguaranteed pricing functions and brief status report on Interim Actuarial Standards Board 'IASB' including how this Committee's Exposure Draft affects the IASB.

Description: Evaluation of the excess mortality element of the Group Conversion charge. Followed by several discussion papers submitted

Description: This 1979 session is about Life Company performance measures and pricing. Topics included: 1. What are appropriate performance criteria? a. In terms of financial results b. In terms of growth 2. How are goals established? a. For Mutual companies b. For Stock companies 3. What measurement tools do we use? a. Comparison of actual to expected results b. Compound growth rates c. Rules of thumb for various performance ratios d. Analysis of source of earnings 4. How are results used in pricing? a. Pricing consistent with goals are goals consistent with projections? b. Problems relating to allocation by line

Description: This article reports on a session at an underwritering meeting in which the panel included an actuary, an underwriter and a marketer. Each presented his point of view about the status of the insurance business and the difficulties of increasing production.

Description: Presented at April 1985 Spring Meeting. Discusses new business developments which have led to a resurgence in term life sales and profitability.

Description: Presented at May 1985 Spring Meeting. This session discussed: Relationship of pricing and valuation actuaries in Canada, Financial reporting system as an information source for product development, Interaction of the pricing actuary, valuation actuary, and investment officer in designing interest-sensitive products, Allocation impact on product development of expense, investment income, tax, and capital, Financial reporting information in changing premium rates for nonguaranteed premium products, Maintaining consistency between pricing and financial projection models, Reserve basis and nonforfeiture basis impact on product development, with special reference to lapse-sensitive products.

Description: Discussion of a direct writer survey and a reinsurer survey conducted in the fall of 2002 by the Society of Actuaries. The surveys asked a number of questions about underwriting criteria needed to qualify for preferred risk. They also asked questions about the percentage of issues in each underwriting category and the mortality assumptions for the different categories.

Description: Discussion of UL products with secondary guarantees and how they are similar to and different from traditional life insurance products. Discussion of possibility they are lapse supported in their pricing.